Month: January 2025

State Contract Pharmacy Lawsuit Weekly Roundup: Updates in West Virginia, Missouri

January 24, 2025 Shannon Young, Associate Editor/Senior Writer Views

Key briefs were filed last week in litigation over state contract pharmacy access laws in West Virginia and Missouri.

Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

NYT Investigation Highlights Federal Law’s Unintended Harm to 340B Providers

January 22, 2025 Bella Czajkowski, National Correspondent Views

A recent New York Times investigation found that part of a COVID-19 relief bill meant to lower drug prices actually increased costs for 340B providers and some of their most vulnerable patients.

A provision in a 2021 COVID-19 relief bill that sought to lower prescription drug prices has actually made some medications [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Four More States Introduce 340B Contract Pharmacy Access Bills in 2025

January 22, 2025 William Newton, Associate Editor/Senior Writer Views

Lawmakers in the Hawaii state legislature recently introduced companion 340B contract pharmacy access bills, and legislators in North Dakota, Oregon and Oklahoma also introduced similar bills.

Hawaii, North Dakota, Oklahoma and Oregon have joined the quickly growing list of states to introduce 340B contract pharmacy access [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Sanofi Reinstates Contract Pharmacy Restrictions in Kansas, West Virginia Following State Legal Developments

January 22, 2025 William Newton, Associate Editor/Senior Writer Views

Sanofi will soon begin restricting 340B contract pharmacy use in Kansas and West Virginia after previously exempting providers in those states.

French pharmaceutical giant Sanofi has reinstated its 340B contract pharmacy restrictions in Kansas and West Virginia following legal developments in [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Cassidy, Sanders Call for Passing Drug Pricing Bills as Key 340B Committee Holds First Meeting; Kennedy Confirmation Stalls

January 22, 2025 Shannon Young, Associate Editor/Senior Writer Views

Senate Health, Education, Labor and Pensions Committee Chairperson U.S. Sen. Bill Cassidy (R-La.) speaks at the panel's first meeting in the 119th Congress on Tuesday.

The Republican and Democratic leaders of the U.S. Senate Health, Energy, Labor and Commerce (HELP) Committee—which has jurisdiction over 340B-related [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Federal 340B Lobbying Activity Held Steady in Q4 of 2024, Filings Show

January 22, 2025 Shannon Young, Associate Editor/Senior Writer Views

More than 350 firms reported lobbying on the 340B program between Oct. 1 and Dec. 31, 2024.

The 340B drug discount program continued to be a hot topic for lobbyists in the final quarter of 2024, keeping [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Just Before Departing, Biden Admin Announces Next 15 Drugs for Medicare Negotiations Amid IRA Uncertainty and 340B Questions

January 22, 2025 Bella Czajkowski and William Newton, National Correspondent Views

The second group of high-cost prescription drugs chosen for Medicare price negotiations were announced last week just ahead of former President Joe Biden's departure from the White House.

The Department of Health and Human Services (HHS) announced the second group of high-cost prescription drugs chosen for Medicare price [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Novartis is Fifth Drugmaker to Sue HRSA to Implement Controversial 340B Rebate Model

January 17, 2025 William Newton, Associate Editor/Senior Writer Views

Novartis is suing HRSA to impose a controversial 340B rebate model that the agency has not authorized.

Novartis this week became the fifth manufacturer to sue the Health Resources and Services Administration (HRSA) to implement a 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

NYT Investigative Article Sparks Both Scrutiny and Support for 340B Prime Vendor Apexus

January 16, 2025 William Newton, Associate Editor/Senior Writer Views

The New York Times published a Jan. 15 investigative article about the 340B prime vendor.

Yesterday’s New York Times investigative article alleging that the 340B prime vendor, Apexus, profited by driving 340B program expansion has [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live